Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay. Nakamura Y, Tsukada Y, Matsuhashi N, Murano T, et al. Clin Cancer Res 2024 Aug 7. doi: 10.1158/1078-0432.CCR-24-1651.

Read + Share

Amedeo Smart

Independent Medical Education

Nakamura Y, Tsukada Y, Matsuhashi N, Murano T, et al. Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay. Clin Cancer Res 2024 Aug 7. doi: 10.1158/1078-0432.CCR-24-1651.
PMID: 39110016